Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: A323990)
Health Care · Biotechnology · KR
₩4,345.00
+1.40% today · -52.0% 1Y
Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: A323990) operates in the Biotechnology industry within the Health Care sector. The company is valued at $75.17M.
Over the last twelve months the share price has lost 52.0%, trading between 3.35K and 11.52K.
Tweenvest scores Vaxcell-Bio Therapeutics Co., Ltd. across four factors: quality 44/100, value 47/100. Its strongest factor is value.
A323990 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $75.17M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.68
- 52-week high
- ₩11,520.00
- 52-week low
- ₩3,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 23.26M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Heron Therapeutics, Inc.NasdaqCM: HRTX | $77.10M | $0.39 | -3.82% |
| Covalon Technologies Ltd.TSXV: COV | $76.84M | CA$4.10 | +3.27% |
| AriBioLab Co.,Ltd.KOSDAQ: A261780 | $76.79M | ₩3,685.00 | +8.06% |
| MedPacto, Inc.KOSDAQ: A235980 | $76.10M | ₩2,985.00 | +0.51% |
| Hofseth BioCare ASAOB: HBC | $75.06M | Nkr1.36 | -1.09% |
| 3D Medicines Inc.SEHK: 1244 | $74.90M | HK$2.39 | -14.34% |
| MediciNova, Inc.NasdaqGM: MNOV | $74.82M | $1.50 | -1.32% |
| OS Therapies IncorporatedNYSEAM: OSTX | $74.72M | $1.45 | -10.49% |
Figures last refreshed Oct 11, 2026.